Oxybutynin 5 mg Immediate Release Tablets is included in the Pill Pass Discount Drug List at Pill Pals Pharmacy. This educational article summarizes key FDA-label topics for patients, caregivers, and prescribers who want a plain-language overview before speaking with a physician or pharmacist.
Drug Name
Oxybutynin 5 mg Immediate Release Tablets
FDA Labeled Indications
Oxybutynin is FDA-labeled for overactive bladder symptoms such as urge urinary incontinence, urgency, and frequency; some products are also labeled for detrusor overactivity associated with neurologic conditions.
Contraindications
Contraindications include urinary retention, gastric retention, uncontrolled narrow-angle glaucoma, and hypersensitivity to oxybutynin.
Warnings
Warnings include angioedema, central nervous system effects, heat prostration, urinary retention, gastrointestinal obstruction, and worsening of glaucoma.
Precautions
Use caution in older adults, dementia risk, kidney or liver impairment, bladder outflow obstruction, gastrointestinal obstruction, reflux disease, myasthenia gravis, autonomic neuropathy, hot environments, and with other anticholinergic drugs.
Adverse Reactions
Adverse reactions may include dry mouth, constipation, blurred vision, dizziness, sleepiness, nausea, dry eyes, urinary retention, and confusion.
Pill Pass Discount Drug List Notes
Availability, quantity limits, manufacturer selection, and final dispensing decisions may depend on prescription requirements, clinical appropriateness, inventory, and applicable law. This article is informational and is not a substitute for individualized medical advice, diagnosis, treatment, or the full FDA-approved labeling for the dispensed product.
Related Pill Pass Discount Drug List Articles
For related medications on the same Pill Pass Discount Drug List, you may also review Oxybutynin 5 mg Extended Release Tablets, Ondansetron 8 mg Tablets, Pantoprazole 20 mg Enteric Coated Tablets, and Ondansetron 4 mg Tablets.
Source note: this article is written as a patient-friendly summary of FDA labeling topics available through DailyMed and related FDA labeling resources. Manufacturer-specific labeling can vary, so patients should rely on the medication guide, package insert, prescriber instructions, and pharmacist counseling for their specific product.
Oxybutynin 5 mg Immediate Release Tablets is on the Pill Pass List. This information is accurate as of May 13, 2026. If you would like more information on this medication, please contact your Physician or Pharmacist.
